- Filed
- May 5, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2026 · May 4, 2026 | 36.43M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 36.58M sh |
| Shares Diluted | Q2 2026 · Mar 31, 2026 | 36.54M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 36.52M sh |
| Shares Diluted restated | Q2 2026 · Mar 31, 2025 | 36.49M sh |
| Dividends Paid | Q2 2026 · Mar 31, 2026 | $6.51M |
| Dividends Paid | Q2 2026 · Mar 31, 2025 | $6.41M |
| Capex | Q2 2026 · Mar 31, 2026 | $3.86M |
| Capex | Q2 2026 · Mar 31, 2025 | $6.26M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2026 | $94.81M |
| Operating Cash Flow | Q2 2026 · Mar 31, 2025 | $59.48M |
| Short Term Investments | Q2 2026 · Mar 31, 2026 | $7.18M |
| Short Term Investments | Q2 2026 · Sep 30, 2025 | $24.79M |
| Cash And Equivalents | Q2 2026 · Mar 31, 2026 | $537.71M |
| Cash And Equivalents | Q2 2026 · Sep 30, 2025 | $450.74M |
| Stockholders Equity | Q2 2026 · Mar 31, 2026 | $709.07M |
| Stockholders Equity | Q2 2026 · Dec 31, 2025 | $668.89M |
| Stockholders Equity | Q2 2026 · Sep 30, 2025 | $640.77M |
| Stockholders Equity | Q2 2026 · Mar 31, 2025 | $541.36M |
| Stockholders Equity | Q2 2026 · Dec 31, 2024 | $496.33M |
| Stockholders Equity | Q2 2026 · Sep 30, 2024 | $483.07M |
| Current Liabilities | Q2 2026 · Mar 31, 2026 | $447.28M |
| Current Liabilities | Q2 2026 · Sep 30, 2025 | $446.39M |
| Total Liabilities | Q2 2026 · Mar 31, 2026 | $470.97M |
| Total Liabilities | Q2 2026 · Sep 30, 2025 | $468.21M |
| Current Assets | Q2 2026 · Mar 31, 2026 | $1.01B |
| Current Assets | Q2 2026 · Sep 30, 2025 | $931.72M |
| Total Assets | Q2 2026 · Mar 31, 2026 | $1.18B |
| Total Assets | Q2 2026 · Sep 30, 2025 | $1.11B |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $1.25 |
| Eps Diluted | Q2 2026 · Mar 31, 2026 | $2.39 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | $1.27 |
| Eps Diluted restated | Q2 2026 · Mar 31, 2025 | $2.22 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $1.26 |
| Eps Basic | Q2 2026 · Mar 31, 2026 | $2.40 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | $1.28 |
| Eps Basic restated | Q2 2026 · Mar 31, 2025 | $2.24 |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $25.84M |
| Sga Expense | Q2 2026 · Mar 31, 2026 | $51M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $21.77M |
| Sga Expense | Q2 2026 · Mar 31, 2025 | $43.24M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $4.29M |
| Rd Expense | Q2 2026 · Mar 31, 2026 | $7.56M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $2.75M |
| Rd Expense | Q2 2026 · Mar 31, 2025 | $5.22M |
| Net Income | Q2 2026 · Mar 31, 2026 | $45.89M |
| Net Income | Q2 2026 · Mar 31, 2026 | $87.28M |
| Net Income | Q2 2026 · Dec 31, 2025 | $41.39M |
| Net Income | Q2 2026 · Mar 31, 2025 | $46.33M |
| Net Income | Q2 2026 · Mar 31, 2025 | $81.09M |
| Net Income | Q2 2026 · Dec 31, 2024 | $34.76M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $57.58M |
| Operating Income | Q2 2026 · Mar 31, 2026 | $100.35M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $58.92M |
| Operating Income | Q2 2026 · Mar 31, 2025 | $94.49M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $87.94M |
| Gross Profit | Q2 2026 · Mar 31, 2026 | $159.35M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $83.43M |
| Gross Profit | Q2 2026 · Mar 31, 2025 | $142.96M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $208.68M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2026 | $388.45M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $195.2M |
| Cost Of Revenue | Q2 2026 · Mar 31, 2025 | $377.11M |
| Revenue | Q2 2026 · Mar 31, 2026 | $296.62M |
| Revenue | Q2 2026 · Mar 31, 2026 | $547.8M |
| Revenue | Q2 2026 · Mar 31, 2025 | $278.63M |
| Revenue | Q2 2026 · Mar 31, 2025 | $520.06M |